With the very recent market approval of pitolisant (Wakix (R)), the interest in clinical applications of novel multifunctional histamine H-3 receptor antagonists has clearly increased. Since histamine H-3 receptor antagonists in clinical development have been tested for a variety of different indications, the combination of pharmacological properties in one molecule for improved pharmacological effects and reduced unwanted side-effects is rationally based on the increasing knowledge on the complex neurotransmitter regulations. The polypharmacological approaches on histamine H-3 receptor antagonists on different G-protein coupled receptors, transporters, enzymes as well as on NO-signaling mechanism are described, supported with some lead structures.
TY - JOUR
AU - Khanfar, Mohammad A.
AU - Affini, Anna
AU - Lutsenko, Kiril
AU - Nikolić, Katarina
AU - Butini, Stefania
AU - Stark, Holger
PY - 2016
UR - http://farfar.pharmacy.bg.ac.rs/handle/123456789/2547
AB - With the very recent market approval of pitolisant (Wakix (R)), the interest in clinical applications of novel multifunctional histamine H-3 receptor antagonists has clearly increased. Since histamine H-3 receptor antagonists in clinical development have been tested for a variety of different indications, the combination of pharmacological properties in one molecule for improved pharmacological effects and reduced unwanted side-effects is rationally based on the increasing knowledge on the complex neurotransmitter regulations. The polypharmacological approaches on histamine H-3 receptor antagonists on different G-protein coupled receptors, transporters, enzymes as well as on NO-signaling mechanism are described, supported with some lead structures.
PB - Frontiers Media Sa, Lausanne
T2 - Frontiers in Neuroscience
T1 - Multiple Targeting Approaches on Histamine H-3 Receptor Antagonists
VL - 10
DO - 10.3389/fnins.2016.00201
ER -
@article{
author = "Khanfar, Mohammad A. and Affini, Anna and Lutsenko, Kiril and Nikolić, Katarina and Butini, Stefania and Stark, Holger",
year = "2016",
url = "http://farfar.pharmacy.bg.ac.rs/handle/123456789/2547",
abstract = "With the very recent market approval of pitolisant (Wakix (R)), the interest in clinical applications of novel multifunctional histamine H-3 receptor antagonists has clearly increased. Since histamine H-3 receptor antagonists in clinical development have been tested for a variety of different indications, the combination of pharmacological properties in one molecule for improved pharmacological effects and reduced unwanted side-effects is rationally based on the increasing knowledge on the complex neurotransmitter regulations. The polypharmacological approaches on histamine H-3 receptor antagonists on different G-protein coupled receptors, transporters, enzymes as well as on NO-signaling mechanism are described, supported with some lead structures.",
publisher = "Frontiers Media Sa, Lausanne",
journal = "Frontiers in Neuroscience",
title = "Multiple Targeting Approaches on Histamine H-3 Receptor Antagonists",
volume = "10",
doi = "10.3389/fnins.2016.00201"
}
Khanfar MA, Affini A, Lutsenko K, Nikolić K, Butini S, Stark H. Multiple Targeting Approaches on Histamine H-3 Receptor Antagonists. Frontiers in Neuroscience. 2016;10
Khanfar, M. A., Affini, A., Lutsenko, K., Nikolić, K., Butini, S.,& Stark, H. (2016). Multiple Targeting Approaches on Histamine H-3 Receptor Antagonists.
Frontiers in NeuroscienceFrontiers Media Sa, Lausanne., 10.
https://doi.org/10.3389/fnins.2016.00201
Khanfar Mohammad A., Affini Anna, Lutsenko Kiril, Nikolić Katarina, Butini Stefania, Stark Holger, "Multiple Targeting Approaches on Histamine H-3 Receptor Antagonists" 10 (2016),
https://doi.org/10.3389/fnins.2016.00201 .
